Burning Rock Biotech (BNR) vs Waters (WAT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Burning Rock Biotech (BNR) has outperformed Waters (WAT) over the past year, gaining 70.8% versus a gain of 31.0%. Over five years, WAT leads with a +24.5% price change compared with -89.4% for BNR. Waters is the larger company by market cap ($42.13 billion vs $160.3 million), about 262.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BNR | WAT |
|---|---|---|
| Share price | $15.20 | $429.13 |
| Market cap | $160.30M | $42.13B |
| 1-day change | +0.13% | -1.57% |
| YTD return | -24.57% | +12.98% |
| 1-year return | +70.79% | +30.97% |
| 5-year return | -89.42% | +24.49% |
| P/E ratio (TTM) | — | 108.64 |
| Forward P/E | — | 25.95 |
| EPS (TTM) | $-0.80 | $3.95 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $3.17B |
| Revenue growth (YoY) | — | +6.99% |
| Net income (latest FY) | — | $642.63M |
| Gross margin | — | 59.28% |
| Operating margin | — | 25.36% |
| Net margin | — | 20.30% |
| 52-week high | $41.72 | $454.54 |
| 52-week low | $6.79 | $282.77 |
| Distance from 52-week high | -63.57% | -5.59% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +6.42% |
| Average volume | 28.59K | 777.61K |
| Shares outstanding | 8.81M | 98.19M |
| Employees | 667 | 16,000 |
| Sector | Health Care | Industrials |
| Industry | Medical Specialities | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Waters is about 262.8 times larger than Burning Rock Biotech by market value ($42.13B vs $160.30M).
- BNR has outperformed WAT by 39.8 percentage points over the past year.
- The two companies sit in different sectors: Burning Rock Biotech in Health Care and Waters in Industrials.
About Burning Rock Biotech
BNR stock →Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services.
Health Care · Medical Specialities · 667 employees
About Waters
WAT stock →Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA.
Industrials · Biotechnology: Laboratory Analytical Instruments · 16,000 employees
BNR vs WAT FAQ
Which is bigger, Burning Rock Biotech or Waters?
Waters (WAT) is larger, with a market capitalization of $42.13B compared with $160.30M for Burning Rock Biotech (BNR).
Which stock has performed better over the past year, BNR or WAT?
BNR returned +70.79% over the past 12 months, compared with +30.97% for WAT (price return, excluding dividends). Past performance does not predict future results.
Are Burning Rock Biotech and Waters in the same industry?
No. Burning Rock Biotech is in the Health Care sector, while Waters is in Industrials.